Wednesday, October 27

Merck to buy Acceleron for about $11.5 bln in rare disease drugs push

Article content

Merck & Co will buy drugmaker

Acceleron Pharma Inc for about $11.5 billion, the

companies said on Thursday, as the US pharmaceutical giant

looks to beef up its portfolio with drugs for rare diseases.

(Reporting by Mrinalika Roy in Bengaluru;

Editing by Vinay Dwivedi and Sriraj kalluvila)

Leave a Reply

Your email address will not be published. Required fields are marked *